| CNCE Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CNCE shares outstanding history going back to 2/13/2014:
Also see: CNCE Market Cap History CNCE YTD Return |
CNCE Shares Outstanding History — Concert Pharmaceuticals Share Count Over Time
As of 11/1/2022 Concert Pharmaceuticals has 47.94 million CNCE shares outstanding. Investors often track the CNCE shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows CNCE share count trends over time, with 37 historical shares outstanding datapoints presented, dating back to 2/13/2014.
| CNCE Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CNCE Historical Shares Outstanding: +13.24% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CNCE Stock Price Chart |
| About Concert Pharmaceuticals Inc |
| Concert Pharmaceuticals is a late-stage clinical biopharmaceutical company that is developing CTP-543, a Janus Kinase 1 and Janus Kinase 2 inhibitor that Co. discovered through the application of its DCE Platform® (deuterated chemical entity platform). Co. is evaluating CTP-543 in a Phase 3 clinical program for the treatment of alopecia areata, a serious autoimmune dermatological condition. In addition to its wholly-owned development programs, Co. has entered into collaborative arrangements with companies to develop deuterium-modified versions of their marketed products. We show 37 historical shares outstanding datapoints in our coverage of CNCE's shares outstanding history. Understanding the changing numbers of CNCE shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CNCE versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CNCE by allowing them to research CNCE shares outstanding history as well as any other stock in our coverage universe. |
| CNCE Current Stock Quote |
Quotes delayed 20 minutes  Free CNCE Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| CNCE Share Performance |
| Shares Outstanding Peers |
| Concert Pharmaceuticals (CNCE) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
CNMD Shares Outstanding History CNSP Shares Outstanding History CNST Shares Outstanding History CNTX Shares Outstanding History CNVY Shares Outstanding History COCP Shares Outstanding History CODX Shares Outstanding History COGT Shares Outstanding History COLL Shares Outstanding History COM Shares Outstanding History More Healthcare companies » |
CNCE Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
